Ken Griffin Jazz Pharmaceuticals PLC Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 30,600 shares of JAZZ stock, worth $3.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,600

Previous 36,200 15.47%

Holding current value

$3.65 Million

Previous $3.86 Million 11.73%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $66.9 Million - $77.4 Million	664,822 Added 171.04%	1,053,521 $117 Million
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $39.3 Million - $45 Million	378,042 Added 3547.36%	388,699 $41.5 Million
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $2.26 Million - $2.6 Million	-19,609 Reduced 64.79%	10,657 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $1.75 Million - $2.08 Million	15,282 Added 101.99%	30,266 $3.72 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $10.7 Million - $12.8 Million	-87,816 Reduced 85.42%	14,984 $1.94 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $20.8 Million - $25 Million	-169,769 Reduced 62.28%	102,800 $12.7 Million
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $47.7 Million - $57.1 Million	-355,919 Reduced 56.63%	272,569 $39.9 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $81.5 Million - $100 Million	628,488 New	628,488 $100 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $25.1 Million - $29.8 Million	176,935 Added 33.37%	707,226 $110 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $57.5 Million - $71.3 Million	443,622 Added 511.86%	530,291 $82.6 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $4.7 Million - $5.71 Million	39,229 Added 82.69%	86,669 $11 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $118 Million - $169 Million	-915,032 Reduced 95.07%	47,440 $6.18 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $61.5 Million - $71.6 Million	-384,050 Reduced 28.52%	962,472 $171 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $59.5 Million - $68.8 Million	396,471 Added 41.73%	1,346,522 $221 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $12.8 Million - $15.1 Million	91,247 Added 10.62%	950,051 $157 Million
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $56.9 Million - $77.8 Million	-539,960 Reduced 38.6%	858,804 $122 Million
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $123 Million - $157 Million	1,286,792 Added 1149.21%	1,398,764 $154 Million
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $65,892 - $114,707	751 Added 0.68%	111,972 $11.2 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $19.1 Million - $24.9 Million	-162,055 Reduced 59.3%	111,221 $16.6 Million
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $13.9 Million - $15.9 Million	111,184 Added 68.59%	273,276 $35 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $7.69 Million - $8.85 Million	-61,255 Reduced 27.43%	162,092 $23.1 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $10.7 Million - $12.6 Million	88,236 Added 65.31%	223,347 $0
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $11 Million - $15.8 Million	94,519 Added 232.85%	135,111 $16.7 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $4.78 Million - $5.36 Million	29,707 Added 272.92%	40,592 $0
Q2 2018 Aug 10, 2018	SELL	$146.33 - $183.18 $7.32 Million - $9.16 Million	-50,010 Reduced 82.12%	10,885 $0
Q1 2018 May 11, 2018	SELL	$135.59 - $157.16 $5.53 Million - $6.41 Million	-40,797 Reduced 40.12%	60,895 $9.2 Million
Q4 2017 Feb 09, 2018	SELL	$131.06 - $150.39 $72 Million - $82.6 Million	-549,231 Reduced 84.38%	101,692 $13.7 Million
Q3 2017 Nov 09, 2017	BUY	$142.62 - $155.6 $92.8 Million - $101 Million	650,923	650,923 $95.2 Million

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.47B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account